Literature DB >> 8543360

Prevalence of hepatitis C virus antibodies in the general population & in selected groups of patients in Delhi.

M Irshad1, S K Acharya, Y K Joshi.   

Abstract

We report on the prevalence of anti-HCV antibodies in healthy individuals and patient groups with different liver diseases. The healthy population comprising 234 voluntary blood donors and 65 pregnant women with no history of liver diseases, had a per cent positivity of 1.5 anti-HCV in each group. The patients groups comprising 32 with acute viral hepatitis, 110 with fulminant hepatic failure, 65 with subacute hepatic failure, 33 with chronic active hepatitis, 45 with cirrhosis and 10 with hepatocellular carcinoma, had anti-HCV per cent positivity of 12.5, 43.6, 41.5, 48.5, 8.8 and 0 respectively. Anti-HCV was also tested in sera from 9 patients who had developed post-transfusion hepatitis and was recorded in 2 (22.2%) within one year of transfusion.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8543360

Source DB:  PubMed          Journal:  Indian J Med Res        ISSN: 0971-5916            Impact factor:   2.375


  5 in total

Review 1.  Hepatitis C in India.

Authors:  Ashis Mukhopadhyaya
Journal:  J Biosci       Date:  2008-11       Impact factor: 1.826

2.  Comparison of 5' noncoding-core with 5' noncoding regions of HCV by RT-PCR: importance and clinical implications.

Authors:  Vikas Verma; Anita Chakravarti
Journal:  Curr Microbiol       Date:  2008-07-09       Impact factor: 2.188

3.  PREVALENCE OF HEPATITIS C VIRUS ANTIBODY IN HETEROGENEOUS POPULATION OF BLOOD DONORS.

Authors:  Y V Machave; P S Dhot
Journal:  Med J Armed Forces India       Date:  2017-06-26

Review 4.  Current molecular methods for the detection of hepatitis C virus in high risk group population: A systematic review.

Authors:  Rushna Firdaus; Kallol Saha; Aritra Biswas; Provash Chandra Sadhukhan
Journal:  World J Virol       Date:  2015-02-12

Review 5.  An insight into the diagnosis and pathogenesis of hepatitis C virus infection.

Authors:  Mohammad Irshad; Dhananjay Singh Mankotia; Khushboo Irshad
Journal:  World J Gastroenterol       Date:  2013-11-28       Impact factor: 5.742

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.